Pear, Sandoz launch first FDA-approved digital therapeutic

Pear Therapeutics Inc. (Boston, Mass.) and Sandoz launched reSET, the first FDA-authorized prescription digital therapeutic, in the U.S. FDA approved reSET in September 2017 to treat substance use disorder in conjunction with outpatient clinician-delivered care.